Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Baxter International Inc. (BAX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
79.24+1.19 (+1.52%)
At close: 04:00PM EST
79.24 0.00 (0.00%)
After hours: 05:29PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close78.05
Open78.39
Bid78.76 x 800
Ask79.17 x 1000
Day's Range78.22 - 80.60
52 Week Range73.12 - 88.32
Volume3,014,923
Avg. Volume2,641,358
Market Cap39.675B
Beta (5Y Monthly)0.61
PE Ratio (TTM)33.35
EPS (TTM)2.38
Earnings DateFeb 02, 2022 - Feb 07, 2022
Forward Dividend & Yield1.12 (1.43%)
Ex-Dividend DateDec 02, 2021
1y Target Est93.79
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-2% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BAX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Baxter International Inc.
    Analyst Report: Baxter International Inc.Baxter manufactures medical products across seven major reported business segments. The renal segment (32% of 2020 sales) includes peritoneal dialysis and hemodialysis products for chronically ill patients while the acute therapies segment (6%) offers kidney or other organ support tools in intensive care situations. The medication delivery segment (23% of sales) sells IV pumps, administrative sets, and solutions while the nutrition segment (8% of sales) offers parenteral nutrition therapies. The pharmaceuticals segment (18% of sales) offers injectable drugs, anesthetic gases, and compounding services. The advanced surgery segment (8% of sales) provides hemostatic products and biosurgical sealants. Contract manufacturing rounds out the remaining sales.
    Rating
    Fair Value
    Economic Moat
    5 days agoMorningstar
View more
Advertisement
Advertisement